help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 18, 2003
Endocrinology, doi:10.1210/en.2003-0812
A more recent version of this article appeared on May 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/5/2118    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hazel, M.
Right arrow Articles by McClain, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hazel, M.
Right arrow Articles by McClain, D. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-DEOXY-D-GLUCOSE

Submitted on June 30, 2003
Accepted on December 11, 2003

Activation of the Hexosamine Signaling Pathway in Adipose Tissue Results in Decreased Serum Adiponectin and Skeletal Muscle Insulin Resistance*

Mark Hazel1, Robert C. Cooksey1, Deborah Jones1, Glendon Parker1, John L. Neidigh1, Bryan Witherbee1, Eric A. Gulve1, and Donald A. McClain1*

1 Department of Medicine, University of Utah, 50 N. Medical Dr., Salt Lake City, UT 84132; VA Medical Center, Salt Lake City, UT 84132; Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216; Cardiovascular and Metabolic Diseases, Pharmacia Corporation, St. Louis, MO 63167

* To whom correspondence should be addressed. E-mail: donald.mcclain{at}hsc.utah.edu.

Overexpression of the rate-limiting enzyme for hexosamine synthesis (glutamine: fructose-6-phosphate amidotransferase, GFA) in muscle and adipose tissue of transgenic mice was previously shown to result in insulin resistance and hyperleptinemia. Explanted muscle from transgenic mice was not insulin resistant in vitro, suggesting that muscle insulin resistance could be mediated by soluble factors from fat tissue. To dissect the relative contributions of muscle and fat to hexosamine-induced insulin resistance, we overexpressed GFA 2.5-fold specifically in fat under control of the aP2 promoter. Fasting glucose, insulin, and triglycerides were unchanged in the transgenic mice; leptin and betahydroxybutyrate levels were 91% and 29% higher, respectively. Fasted transgenic mice have mild glucose intolerance and skeletal muscle insulin resistance in vivo. In fasting transgenic mice, glucose disposal rates with hyperinsulinemia were decreased 27% in females and 10% in males. Uptake of 2-deoxy-D-glucose into muscle was diminished by 45% in female and 21% in male transgenics. Serum adiponectin was also lower in the fasted transgenics, by 37% in females and 22% in males. TNF{alpha} and resistin mRNA levels in adipose tissue were not altered in the fasted transgenics; levels of mRNA for leptin were increased and PPAR{gamma} decreased. To further explore the relationship between adiponectin and insulin sensitivity, we examined mice that has been refed for 6 h after a 24 h fast. Refeeding wild-type mice resulted in decreased serum adiponectin and increased leptin. In transgenic mice, however, the regulation of these hormones by refeeding was lost for adiponectin and diminished for leptin. Refed transgenic female and male mice no longer exhibited decreased serum adiponectin in the refed state, and they were no longer insulin resistant as by lower or unchanged insulin and glucose levels. We conclude that increased hexosamine levels in fat, mimicking excess nutrient delivery, are sufficient to cause insulin resistance in skeletal muscle. Changes in serum adiponectin correlate with the insulin resistance of the transgenic animals.


Key words: Adiponectin • hexosamine • insulin resistance • GFA • adipose tissue




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Luo, G. J. Parker, R. C. Cooksey, Y. Soesanto, M. Evans, D. Jones, and D. A. McClain
Chronic Hexosamine Flux Stimulates Fatty Acid Oxidation by Activating AMP-activated Protein Kinase in Adipocytes
J. Biol. Chem., March 9, 2007; 282(10): 7172 - 7180.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Teta, M. Maillard, A. Tedjani, J. Passlick-Deetjen, and M. Burnier
The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. A. Robinson, L. E. Ball, and M. G. Buse
Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E884 - E890.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
S. Marshall
Role of Insulin, Adipocyte Hormones, and Nutrient-Sensing Pathways in Regulating Fuel Metabolism and Energy Homeostasis: A Nutritional Perspective of Diabetes, Obesity, and Cancer
Sci. Signal., August 1, 2006; 2006(346): re7 - re7.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. M. Gronning, R. Tingsabadh, K. Hardy, K. T. Dalen, P. S. Jat, L. Gnudi, and P. R. Shepherd
Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E599 - E606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Qiao, J. Schaack, and J. Shao
Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid
Endocrinology, February 1, 2006; 147(2): 865 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Cooksey, S. Pusuluri, M. Hazel, and D. A. McClain
Hexosamines regulate sensitivity of glucose-stimulated insulin secretion in {beta}-cells
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E334 - E340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse
Hexosamines, insulin resistance, and the complications of diabetes: current status
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Lazarus, M. D. Roos, and J. A. Hanover
Mutational Analysis of the Catalytic Domain of O-Linked N-Acetylglucosaminyl Transferase
J. Biol. Chem., October 21, 2005; 280(42): 35537 - 35544.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Fisher, J. C. Bruning, S. Lannon, and C. R. Kahn
Insulin Signaling in the Central Nervous System Is Critical for the Normal Sympathoadrenal Response to Hypoglycemia
Diabetes, May 1, 2005; 54(5): 1447 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. McClain, M. Hazel, G. Parker, and R. C. Cooksey
Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E973 - E979.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. H. Einstein, G. Atzmon, X.-m. Yang, X.-H. Ma, M. Rincon, E. Rudin, R. Muzumdar, and N. Barzilai
Differential Responses of Visceral and Subcutaneous Fat Depots to Nutrients
Diabetes, March 1, 2005; 54(3): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Cheatham
Enough Is Enough: Nutrient Sensors and Insulin Resistance
Endocrinology, May 1, 2004; 145(5): 2115 - 2117.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society